Dr Reddy’s Strikes $67m Deal With Alvotech On Denosumab
Indian Firm Gains Rights In US And Europe; Builds Infrastructure For Biosimilars Unit
Dr Reddy’s has announced a denosumab licensing deal with Alvotech covering the US and Europe, for which the Indian company has broken down the financial details. More broadly, the alliance will also allow Dr Reddy’s to build up its commercial infrastructure for biosimilars in both key markets.
